Healthcare DIVE May 22, 2024
Sydney Halleman

Drugmakers are allowed to impose conditions on which pharmacies they dispense discounted drugs to in the 340B program, according to an appellate court.

Dive Brief:

  • Drugmakers are allowed to limit and impose conditions on pharmacies they send discounted drugs to under the 340B program, an appeals court ruled Tuesday.
  • The ruling is a win for drug manufacturers, who were previously threatened with fines from the federal government for violating guidance regarding which pharmacies they would send discounted drugs to.
  • The Court of Appeals upholds a prior District Court ruling, which sided with drugmakers Novartis Pharmaceuticals and United Therapeutics after they sued the HHS in 2021. It’s the latest ruling regarding the controversial 340B drug program — a separate appellate...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Govt Agencies, HHS, Insurance, Pharma, Pharma / Biotech, Provider
Related Articles:
Why doctors increasingly turn away from rural clinical practice
More than half of US adults could benefit from GLP-1 medications, researchers find
Concerns raised over Indiana hospital merger
Self-governance in the medical profession and medical malpractice
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders

Share This Article